LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers

समान संसाधन

• LUD00-014: Phase I Study of recombinant vaccinia-NY-ESO-1 (rV-NY-ESO-1) and recombinant fowlpox-NY-ESO-1 (rF-NY-ESO-1) in patients with NY-ESO-1 or LAGE positive cancers
  द्वारा: Knuth A, और अन्य
  प्रकाशित: (2004-07-01)
• Monitoring CD8 T cell responses to NY-ESO-1: Correlation of humoral and cellular immune responses
  द्वारा: Jäger, Elke, और अन्य
  प्रकाशित: (2000)
• Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele
  द्वारा: Gnjatic, Sacha, और अन्य
  प्रकाशित: (2000)
• Survey of naturally occurring CD4(+) T cell responses against NY-ESO-1 in cancer patients: Correlation with antibody responses
  द्वारा: Gnjatic, Sacha, और अन्य
  प्रकाशित: (2003)
• Differential presentation of a soluble exogenous tumor antigen, NY-ESO-1, by distinct human dendritic cell populations
  द्वारा: Nagata, Yasuhiro, और अन्य
  प्रकाशित: (2002)